Akums Drugs and Pharmaceutical Cash Flow Quality Index
Akums Drugs and Pharmaceutical cash flow quality index. Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Quality Index of 11.05x as of September 2025. Operating cash flow of Rs11.52 Billion exceeds net income of Rs1.04 Billion, indicating high earnings quality where cash backs reported profits. See Akums Drugs and Pharmaceutical free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Akums Drugs and Pharmaceutical (2023–2026)
Cash flow quality index of Akums Drugs and Pharmaceutical from 2023 to 2026. Historical Cash Flow Quality Index for Akums Drugs and Pharmaceutical across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Akums Drugs and Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Akums Drugs and Pharmaceutical Cash Flow Quality Index by Year (2023–2026)
Akums Drugs and Pharmaceutical cash flow quality index by year from 2023 to 2026. Year-by-year earnings quality comparison for Akums Drugs and Pharmaceutical. For the full cash flow conversion analysis, see AKUMS cash flow metrics.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 4.74x | Rs12.11 Billion | Rs2.55 Billion | ▲ +252.1% |
| 2025 | 1.35x | Rs4.65 Billion | Rs3.45 Billion | ▲ +14.7% |
| 2023 | 1.18x | Rs1.77 Billion | Rs1.50 Billion | — |